2024 · Bioanalysis · open access
Patient-centric microsampling for abrocitinib pharmacokinetics: multiple-analytes assay bridging using Tasso device
Tripathy et al.
The finding, in our words
Capillary serum collected with Tasso-SST and Tasso+ devices correlated with venous plasma at r = 0.98 for abrocitinib and its three metabolites, and exposure met bioequivalence criteria; the authors present this as the basis for using Tasso devices in future paediatric studies of abrocitinib.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.